Ivor MacLeod
Director of Finance/CFO en SCYNEXIS, INC. .
Fortuna: 235 506 $ al 31/03/2024
Perfil
Ivor MacLeod is currently the Chief Financial & Accounting Officer at SCYNEXIS, Inc. Prior to this, he held positions as Vice President-Finance at Merck & Co., Inc., Vice President-Finance & Information Technology at Hoffmann-La Roche, Inc., and Chief Financial & Compliance Officer, SVP at Eisai, Inc. From 2021 to 2022, he served as the Chief Financial & Accounting Officer at Athersys, Inc. Mr. MacLeod completed his undergraduate degree at the University of St. Andrews and holds an MBA from Eller College of Management.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SCYNEXIS, INC.
0.43% | 26/01/2024 | 160 185 ( 0.43% ) | 235 472 $ | 31/03/2024 |
ATHERSYS, INC.
0.01% | 14/08/2023 | 5 732 ( 0.01% ) | 34 $ | 31/03/2024 |
Cargos activos de Ivor MacLeod
| Empresas | Cargo | Inicio |
|---|---|---|
| SCYNEXIS, INC. | Director of Finance/CFO | 24/10/2022 |
Antiguos cargos conocidos de Ivor MacLeod.
| Empresas | Cargo | Fin |
|---|---|---|
| ATHERSYS, INC. | Director of Finance/CFO | 30/06/2022 |
| MERCK & CO., INC. | Director of Finance/CFO | - |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Director of Finance/CFO | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Director of Finance/CFO | - |
Formación de Ivor MacLeod.
| University of St. Andrews | Undergraduate Degree |
| Eller College of Management | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SCYNEXIS, INC. | Health Technology |
| ATHERSYS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Ivor MacLeod
